Skip to content. | Skip to navigation

CREATE-MIA!

Personal tools

This is SunRain Plone Theme
You are here: Home / Training / 2017 / A brief overview of PET quantification

A brief overview of PET quantification

Min Su (Peter) Kang, PhD Candidate, MNI

A brief overview of PET quantification

Min Su Kang

What
  • CREATE-MIA Event
  • Seminar
When Dec 08, 2017
from 04:00 PM to 05:00 PM
Attendees All CREATE-MIA Trainees
Add event to calendar vCal
iCal

Abstract

Positron Emission Tomography (PET) is a powerful in vivo imaging technique that allows for quantification of numerous biological process of interest such as  receptors (dopamine, serotonin, acetylcholine, glutamate, GABA, etc) or abnormal protein aggregates (amyloid plaques, neurofibrillary tangles, etc) or brain functions (blood flow or glucose uptake). Development of novel PET tracers and methodologies has advanced the understanding of pathophysiology of various neurodegenerative diseases and it plays a crucial role as a clinical diagnostic tool. This presentation will discuss the theoretical basis behind brain PET quantification, different kinetic models and methodologies, and practical approach for using PET in research and clinical settings.

Biography 

Min Su (Peter) Kang is a Ph.D. candidate who is currently working on the development of translational neuroscience framework, in which investigates the effects of amyloidosis in Alzheimer’s disease (AD) spectrum using multimodal imaging techniques and fluid biomarkers. Min Su (Peter) utilizes Positron Emission Topography (PET), Magnetic Resonance Imaging (MRI), Cerebrospinal fluid (CSF), and plasma to characterize the relationship between amyloidosis and various pathophysiological processes observed in AD spectrum using McGill-R-Thy1-APP transgenic rat model and Alzheimer’s Disease Neuroimaging Initiative (ADNI) database.

Filed under: , ,
« December 2019 »
December
SuMoTuWeThFrSa
1234567
891011121314
15161718192021
22232425262728
293031
Funded by NSERC

Funding provided by NSERC